Nintedanib Plus Usual Transplant Care Compared to Usual Transplant Care Alone After Single Lung Transplantation in Patients With Idiopathic Pulmonary Fibrosis: a Pilot Randomized Controlled Trial
Phase of Trial: Phase II
Latest Information Update: 11 Jul 2019
Price : $35 *
At a glance
- Drugs Nintedanib (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 11 Jun 2019 Status changed from not yet recruiting to recruiting.
- 12 Feb 2019 Planned initiation date changed from 1 Oct 2018 to 1 Apr 2019.
- 27 Jun 2018 New trial record